ADAR1 has also been suggested as a therapeutic target against gastric cancer metastasis, since ADAR1 knockdown suppressed peritoneal metastasis of gastric cancer in mouse models partially by inhibiting Wnt/β-catenin pathway and EMT [380]. Here, ADAR is linked to gastric cancer.